These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 26822918)

  • 1. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry.
    Boersma LV; Schmidt B; Betts TR; Sievert H; Tamburino C; Teiger E; Pokushalov E; Kische S; Schmitz T; Stein KM; Bergmann MW;
    Eur Heart J; 2016 Aug; 37(31):2465-74. PubMed ID: 26822918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up.
    Phillips KP; Pokushalov E; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2018 Jun; 20(6):949-955. PubMed ID: 29106523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry.
    Phillips KP; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2020 Feb; 22(2):225-231. PubMed ID: 31665276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry.
    Phillips KP; Santoso T; Sanders P; Alison J; Chan JLK; Pak HN; Chandavimol M; Stein KM; Gordon N; Razali OB
    Int J Cardiol Heart Vasc; 2019 Jun; 23():100358. PubMed ID: 31008181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Foley D; Sievert H; Mazzone P; De Potter T; Vireca E; Stein K; Bergmann MW;
    Heart Rhythm; 2017 Sep; 14(9):1302-1308. PubMed ID: 28577840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation.
    Panikker S; Lord J; Jarman JW; Armstrong S; Jones DG; Haldar S; Butcher C; Khan H; Mantziari L; Nicol E; Hussain W; Clague JR; Foran JP; Markides V; Wong T
    Eur Heart J; 2016 Dec; 37(46):3470-3482. PubMed ID: 26935273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.
    Sedaghat A; Nickenig G; Schrickel JW; Ince H; Schmidt B; Protopopov AV; Betts TR; Gori T; Sievert H; Mazzone P; Grygier M; Wald C; Vireca E; Allocco D; Boersma LVA;
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1019-E1024. PubMed ID: 33417282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Left Atrial Appendage Closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS Registry.
    Mazzone P; D'Angelo G; Regazzoli D; Molon G; Senatore G; Saccà S; Canali G; Amellone C; Turri R; Bella PD
    J Interv Card Electrophysiol; 2018 Jun; 52(1):47-52. PubMed ID: 29525913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
    Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
    Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
    Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
    J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry.
    Bergmann MW; Betts TR; Sievert H; Schmidt B; Pokushalov E; Kische S; Schmitz T; Meincke F; Stein KM; Boersma LVA; Ince H
    EuroIntervention; 2017 Sep; 13(7):877-884. PubMed ID: 28606886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology.
    Boersma LV; Schmidt B; Betts TR; Sievert H; Tamburino C; Teiger E; Stein KM; Bergmann MW
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):460-5. PubMed ID: 26719158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study.
    Bergmann MW; Ince H; Kische S; Schmitz T; Meincke F; Schmidt B; Foley D; Betts TR; Grygier M; Protopopov AV; Stein KM; Boersma LVA
    EuroIntervention; 2018 Apr; 13(17):2003-2011. PubMed ID: 29313819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
    Xue X; Jiang L; Duenninger E; Muenzel M; Guan S; Fazakas A; Cheng F; Illnitzky J; Keil T; Yu J
    Heart Vessels; 2018 Sep; 33(9):1068-1075. PubMed ID: 29564543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation.
    Chen S; Chun KRJ; Bordignon S; Weise FK; Nagase T; Perrotta L; Bologna F; Schmidt B
    J Cardiol; 2019 Apr; 73(4):299-306. PubMed ID: 30583991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.
    Bonnet G; Salaun E; Pankert M; Cuisset T; Bonnet JL
    Arch Cardiovasc Dis; 2016 Dec; 109(12):689-695. PubMed ID: 27594651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization and procedural adverse outcomes associated with Watchman device implantation.
    Khalil F; Arora S; Killu AM; Tripathi B; DeSimone CV; Egbe A; Noseworthy PA; Kapa S; Mulpuru S; Gersh B; Mohamad A; Friedman P; Holmes D; Deshmukh AJ
    Europace; 2021 Feb; 23(2):247-253. PubMed ID: 32929501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.